Anti-Xa levels and renal function: Analysis of the first 32 patients in the tinzaparin in renal insufficiency for venous thromboembolism study

被引：0
|
作者：
Lim, W
Douketis, J
Wang, LQ
Woods, K
Schnurr, T
Kinnon, K
Cruickshank, R
Clase, CM
Crowther, MA
Rabbat, C
Crowther, MA
机构：
[1] McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada
[2] St Josephs Hosp, Hamilton, ON, Canada
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
906
引用
收藏
页码：266A / 266A
页数：1
相关论文
共 50 条
  • [1] Empirically Reduced Dosages of Tinzaparin in Patients with Moderate-to-Severe Renal Insufficiency Lead to Inadequate Anti-Xa Levels
    Olie, Renske H.
    Meertens, Nathalie E. L.
    Henskens, Yvonne M. C.
    ten Cate, Hugo
    [J]. NEPHRON, 2017, 137 (02) : 113 - 123
  • [2] Enoxaparin titrated by anti-Xa levels reduces venous thromboembolism in trauma patients
    Gates, Rebecca S.
    Lollar, Daniel, I
    Collier, Bryan R.
    Smith, Jacob
    Faulks, Emily R.
    Gillen, Jacob R.
    [J]. JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2022, 92 (01): : 93 - 97
  • [3] Evaluation of anti-Xa levels in patients with venous thromboembolism within the first 48 h of anticoagulation with unfractionated heparin
    Nguyen, Lily
    Qi, Xiaoxiao
    Karimi-asl, Abraham
    Thole, Alicia
    Wendte, Jodi
    Meissner, Tobias
    Xu, Bing
    Dvoracek, Kyle
    [J]. SAGE OPEN MEDICINE, 2023, 11
  • [4] Association of outcomes and anti-Xa levels in the treatment of pediatric venous thromboembolism
    Fan, Jennifer L.
    Roberts, Laura E.
    Scheurer, Michael E.
    Yee, Donald L.
    Shah, Mona D.
    Lee-Kim, YoungNa J.
    [J]. PEDIATRIC BLOOD & CANCER, 2017, 64 (11)
  • [5] Effect of LMWH (Tinzaparin) post surgery in gynaecological patients: a study of anti-Xa activity levels
    Ibrahim, N.
    Norris, L.
    O'Toole, S.
    Gleeson, N.
    [J]. THROMBOSIS RESEARCH, 2014, 133 : S204 - S204
  • [6] Impact of Increased Enoxaparin Dosing on Anti-Xa Levels for Venous Thromboembolism Prophylaxis in Trauma Patients
    Bellfi, Lillian T.
    Zimmerman, S. Anthony
    Boudreau, Ryan
    Mosier, Willard, Jr.
    Smith, Alison
    Rueb, Nicole
    Hunt, John P.
    Stuke, Lance
    Greiffenstein, Patrick
    Schoen, Jonathan
    Marr, Alan
    [J]. AMERICAN SURGEON, 2022, 88 (09) : 2158 - 2162
  • [7] Monitoring anti-Xa levels in patients with cancer-associated venous thromboembolism treated with bemiparin
    F. Galeano-Valle
    G. Pérez-Rus
    P. Demelo-Rodríguez
    L. Ordieres-Ortega
    L. Ortega-Morán
    A. J. Muñoz-Martín
    S. Medina-Molina
    L. A. Alvarez-Sala-Walther
    J. del-Toro-Cervera
    [J]. Clinical and Translational Oncology, 2020, 22 : 1312 - 1320
  • [8] Monitoring anti-Xa levels in patients with cancer-associated venous thromboembolism treated with bemiparin
    Galeano-Valle, F.
    Perez-Rus, G.
    Demelo-Rodriguez, P.
    Ordieres-Ortega, L.
    Ortega-Moran, L.
    Munoz-Martin, A. J.
    Medina-Molina, S.
    Alvarez-Sala-Walther, L. A.
    del-Toro-Cervera, J.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (08): : 1312 - 1320
  • [9] Use of therapeutic dose low molecular weight heparin in patients with renal insufficiency: Analysis of anti-Xa levels and creatinine clearance.
    Lim, Wendy
    Sridhara, Manasa
    Wang, Luqi
    Kinnon, Krystyna
    Douketis, James
    Crowther, Mark
    [J]. BLOOD, 2006, 108 (11) : 265A - 265A
  • [10] A RETROSPECTIVE STUDY OF ANTI-XA ACTIVITY IN PATIENTS WITH RENAL INSUFFICIENCY RECEIVING RENAL-BASED REDUCED OR NOT-REDUCED THERAPEUTIC DOSES OF DALTEPARIN
    Mitrov-winkelmolen, L.
    Pires, K.
    Le, H.
    Bouwhuis, J.
    Kuijper, M.
    Bosch, T.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 78 (SUPPL 1) : S21 - S22
12345